Join

Compare · DXCM vs SRTS

DXCM vs SRTS

Side-by-side comparison of DexCom Inc. (DXCM) and Sensus Healthcare Inc. (SRTS): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both DXCM and SRTS operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • DXCM is the larger of the two at $23.76B, about 366.3x SRTS ($64.9M).
  • Over the past year, DXCM is down 13.5% and SRTS is down 15.9% - DXCM leads by 2.4 points.
  • SRTS has been more active in the news (5 items in the past 4 weeks vs 4 for DXCM).
  • DXCM has more recent analyst coverage (25 ratings vs 8 for SRTS).
PerformanceDXCM-13.51%SRTS-15.86%
2025-04-28+0.00%2026-04-24
MetricDXCMSRTS
Company
DexCom Inc.
Sensus Healthcare Inc.
Price
$61.55-1.84%
$3.98-0.75%
Market cap
$23.76B
$64.9M
1M return
-7.89%
-5.69%
1Y return
-13.51%
-15.86%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NASDAQ
IPO
2005
2016
News (4w)
4
5
Recent ratings
25
8
DXCM

DexCom Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

SRTS

Sensus Healthcare Inc.

Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary modulated robotic brachytherapy oncology therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Latest DXCM

Latest SRTS